Page last updated: 2024-08-17

carbostyril and Infections, Helicobacter

carbostyril has been researched along with Infections, Helicobacter in 81 studies

Research

Studies (81)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (11.11)18.2507
2000's34 (41.98)29.6817
2010's31 (38.27)24.3611
2020's7 (8.64)2.80

Authors

AuthorsStudies
Areia, M; Barrio, J; Beglinger, C; Bordin, D; Boyanova, L; Bujanda, L; Buzas, GM; Bytzer, P; Caldas, M; Capelle, L; Castro-Fernandez, M; Doulberis, M; Fernandez-Salazar, L; Gasbarrini, A; Gisbert, JP; Goldis, A; Huguet, JM; Jonaitis, L; Jurecic, NB; Kunovský, L; Kupčinskas, J; Lamy, V; Lanas, A; Lasala, JP; Leja, M; Lerang, F; Lucendo, AJ; Marcos-Pinto, R; Marlicz, W; Megraud, F; Milivojevic, V; Molina-Infante, J; Morain, CO; Niv, Y; Nyssen, OP; Ortuño, J; Pérez Aísa, Á; Phull, P; Puig, I; Rodrigo, L; Rokkas, T; Sarsenbaeva, AS; Shvets, O; Simsek, I; Smith, S; Tepes, B; Tonkić, A; Vaira, D; Venerito, M; Vologzhanina, L; Voynovan, I1
Niu, Z; Ren, X; Song, Z; Suo, B; Tian, X; Xue, Y; Zhou, L1
Babic, I; Gisbert, J; Kekic, D; Krstic, M; Mégraud, F; Milivojevic, V; Milosavljevic, T; Moreira, L; Nyssen, OP; O' Morain, C; Panic, N; Rankovic, I; Sagdati, S; Spasic, IS1
Desai, T; Edhi, AI; Hakim, S1
Chang, YL; Hsu, PI; Kim, SE; Liou, WS; Shiu, SI; Tu, YK; Tung, YC; Wu, MF; Yang, JC; Yeh, HZ1
Cao, M; Chen, H; Cram, DS; Liu, X; Lv, N; Lv, T; Wang, H; Xie, Y; Zhang, C; Zhong, J; Zhou, L1
Andreev, DN; Maev, IV1
Bae, HI; Jeon, SW; Kwon, YH; Lee, HS; Lee, JS; Nam, SY; Seo, AN1
Gisbert, JP; Marin, AC; McNicholl, AG; Nyssen, OP1
Bilgilier, C; Biowski-Frotz, S; Blesl, A; Datz, C; Effenberger, M; Gombotz, G; Graziadei, I; Hinterberger, I; Hirschl, AM; Högenauer, C; Huber-Schönauer, U; Hubmann, R; Kastner, MT; Klimpel, S; Knoflach, P; Kundi, M; Leiner, J; Ludwiczek, O; Makristathis, A; Mitrovits, N; Moser, M; Püspök, A; Schöfl, R; Schöniger-Hekele, M; Schrutka-Kölbl, C; Siebert, F; Stadlmann, A; Steiner, P; Steininger, C; Stupnicki, T; Thannesberger, J; Tilg, H; Watzinger, N; Wewalka, F; Wurzer, H1
Mori, H; Suzuki, H1
Abe, H; Adachi, H; Amalia, E; Hayashi, C; Igarashi, M; Inaoka, DK; Kawada, M; Kita, K; Masuda, T; Mimuro, H; Mochizuki, K; Ohba, SI; Ohishi, T; Shibasaki, M; Watanabe, T1
Chung, JW; Kim, J; Kim, K; Kim, KO; Kim, SY; Kim, YJ; Kwon, KA; Lee, JS; Park, DK1
An, Y; Fu, YJ; Li, Z; Qian, X; Wang, Y; Wang, YH; Wu, S; Xie, Y1
Ho, HJ; Hsu, CC; Lee, CC; Lin, JT; Liou, JM; Wu, CY; Wu, MS; Yeo, YH1
Andreev, DN; Dicheva, DT; Maev, IV; Partzvania-Vinogradova, EV; Samsonov, AA1
Furuta, T; Handa, O; Kato, M; Kikuchi, S; Mabe, K; Murakami, K; Okuda, M; Ota, H; Satoh, K; Shimoyama, T; Sugiyama, T; Suzuki, H; Takahashi, S; Uemura, N1
Jaka, H; Kasang, C; Mshana, SE; Mueller, A1
de Andrés, E; Gómez Hernando, C; Gómez Rodríguez, R; Muñoz Gómez, P; Sierra Bernal, C; Valle Muñoz, J1
Glocker, EO; Kist, M; Stueger, HP; Wueppenhorst, N1
Bazzoli, F; Calvet, X; Fallone, C; Fischbach, L; Ford, AC; Forman, D; Gisbert, JP; Khan, KJ; Leontiadis, GI; Moayyedi, P; Oderda, G; Tse, F; Yuan, Y1
Kim, N; Lee, JY1
Azuma, T; Higuchi, K; Iguchi, M; Machida, H; Morita, Y; Naito, Y; Takeuchi, T; Takeuchi, Y; Tamada, T; Tominaga, K; Uedo, N; Yagi, N; Yamao, J; Yazumi, S1
Chuah, SK; Hu, TH; Lee, CH; Liang, CM; Tai, WC1
Kanai, T; Nishizawa, T; Nishizawa, Y; Suzuki, H; Takahashi, M; Yahagi, N1
Fischbach, W; Glocker, E; Malfertheiner, P; Scherübl, H1
Akiyama, T; Haruma, K; Hata, J; Inoue, K; Ito, M; Kamada, T; Manabe, N; Matsumoto, H; Murao, T; Sato, M; Shiotani, A; Tanaka, S; Tokutomi, T; Watanabe, T1
Chen, X; Han, X; Jiang, K; Li, S; Wang, B; Zhou, L1
Chao, CY; Che, YJ; Kao, CY; Lee, GB; Wang, CH; Wu, JJ1
Choi, KY; Hwang, WC; Kang, DW; Min, do S; Noh, YN1
Ichikawa, T; Iijima, K; Koike, T; Ogawa, M; Ohara, S; Okada, S; Shimosegawa, T1
Hibi, T; Iwasaki, E; Masaoka, T; Minegishi, Y; Nakagawa, I; Nishizawa, T; Suzuki, H1
Chayanupatkul, M; Klaikeaw, N; Mahachai, V; Rerknimitr, R; Thong-Ngam, D1
Furuta, T1
Naito, Y; Yoshikawa, T1
Hsueh, PR; Lee, PI; Yang, JC1
Higuchi, W; Kanda, H; Takano, T; Yamamoto, T1
Furuta, T; Kodaira, C; Nishino, M; Sugimoto, M; Uotani, T; Yamade, M1
Bo, J; Chen, MH; Fan, DM; Ge, ZZ; Ji, F; Jung, HC; Kim, JH; Lee, SW; Lee, YC; Song, KH1
Bornschein, J; Malfertheiner, P; Selgrad, M1
Chang, WL; Cheng, HC; Huang, AH; Kao, CY; Sheu, BS; Wu, CT; Wu, JJ; Yang, HB1
Chin, YW; Chung, YH; Jung, K; Kim, J; Lee, B; Min, DS; Park, YH; Yoo, H1
Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Tanigawa, T; Tominaga, K; Wada, R; Watanabe, T1
Haga, K; Hirayama, F; Iwao, E; Takagi, S; Yamamoto, K; Yokoyama, Y1
Adachi, K; Fujishiro, H; Kinoshita, Y; Komazawa, Y; Mihara, T1
Cho, SW; Hahm, KB; Han, SU; Kim, DY; Kim, JH; Kim, MW; Kim, YB; Lee, JS; Nahm, KT; Oh, TY; Song, YJ; Surh, YJ; Yoo, BM1
Bello, A; Christopher, L; Gajjar, DA; Ge, Z; Grasela, DM1
Genta, RM1
Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Oshitani, N; Sasaki, E; Shiba, M; Takashima, T; Tanigawa, T; Tominaga, K; Watanabe, T1
Cho, SW; Cho, YK; Hahm, KB; Joo, HJ; Kim, DH; Kim, JH; Kim, YB; Lee, JS; Lee, KM; Nam, KT; Surh, YJ; Yoo, BM1
Akiba, Y; Ishii, H; Matsui, H; Nakamura, M; Tsuchimoto, K1
Arakawa, T; Asaka, M; Fujioka, T; Ishii, H; Itoh, M; Kawai, S; Kobayashi, K; Kuwayama, H; Sato, R; Shimoyama, T; Takemoto, T; Yoshikawa, T1
Bevilacqua, C; Gaboriau-Routhiau, V; Heyman, M; Matysiak-Budnik, T; Mayo, K; Mégraud, F; Moreau, MC; van Niel, G1
Arakawa, T; Fujiwara, Y; Higuchi, K; Tominaga, K; Watanabe, T1
Arakawa, T; Fujiwara, Y; Hamasaki, N; Higuchi, K; Ishii, E; Kadota, S; Nagaoka, T; Oshitani, N; Sasaki, E; Tanigawa, T; Tezuka, Y; Tominaga, K; Watanabe, T1
Arakawa, T; Asaka, M; Fujioka, T; Haruma, K; Ishii, H; Kinoshita, Y; Kobayashi, K; Sakaki, N; Sakamoto, C; Shimosegawa, T; Sugiyama, T; Takahashi, S; Terano, A; Yoshikawa, T1
Glocker, E; Kist, M; Stueger, HP1
Asencio, C; Candalh, C; Heyman, M; Laharie, D; Matysiak-Budnik, T; Mégraud, F; Ménard, S; Rullier, A; Vidal-Martinez, T; Zerbib, F1
Fukui, H; Takakura, Y; Yajima, H; Yamao, J1
Arakawa, T; Haruma, K; Higuchi, K; Joh, T; Kobayashi, K; Murakami, K; Sugiyama, T; Suzuki, H; Terano, A; Yoshikawa, T1
Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A1
Chen, J; Du, Y; Fang, D; Gao, J; Gong, Y; Guo, X; He, L; Jiang, B; Li, Y; Li, Z; Ren, J; Shi, R; Tian, Z; Wu, J; Zhan, X; Zhang, Z1
Chitapanarux, T; Lertprasertsuke, N; Praisontarangkul, OA1
Cho, SW; Hahm, KB; Joo, HJ; Kim, JH; Kim, YS; Lee, KJ; Yim, H2
Cho, SW; Chung, MH; Hahm, KB; Kim, JH; Lee, KJ1
Ando, K; Arakawa, T; Fujiwara, Y; Fukuda, T; Higuchi, K; Kobayashi, K; Kuroki, T; Nebiki, H; Takaishi, O; Uchida, T; Yamasaki, K1
Ishii, H; Kai, A; Miura, S; Mori, M; Suematsu, M; Suzuki, H; Suzuki, M1
Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Kudo, M; Nishikawa, K; Sato, F; Sugiyama, T; Sukegawa, M; Takeda, H1
Ando, K; Arakawa, T; Harihara, S; Higuchi, K; Ito, H; Kobayashi, K; Kuroki, T; Nebiki, H; Uchida, T1
Hirayama, F; Ikeda, Y; Kawakita, T; Kuroda, T; Moriguchi, A; Sakurai, N; Sano, M; Uemori, S; Yamamoto, K1
Abely, M; de Mascarel, A; Heyman, M; Matysiak-Budnik, T; Mayo, K; Mégraud, F1
Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T1
Masamune, A; Sakai, Y; Shimosegawa, T; Yoshida, M1
Heyman, M; Matysiak-Budnik, T; Mégraud, F; Thomas-Collignon, A1
Marcuard, SP; Riff, DS; Schwartz, H; Talley, NJ1
Inaba, T; Kawai, K; Kita, K; Mizuno, M; Okada, H; Takaguchi, K; Tsuji, T; Yoshida, Y1
Choi, KW; Choi, MG; Chung, IS; Chung, MH; Hahm, KB; Hong, WS; Jung, HY; Kim, JG; Kim, JH; Kim, NY; Kim, SW; Lee, JJ; Lee, SW; Lee, YC; Roe, IH1
Fukuda, S; Liu, Q; Shimoyama, T; Sugawara, K1
Chayama, K; Haruma, K; Ito, M; Kido, S; Kitadai, Y; Manabe, N; Sumii, M; Tanaka, S; Yoshihara, M1
Burette, A; Glupczynski, Y1

Reviews

19 review(s) available for carbostyril and Infections, Helicobacter

ArticleYear
Efficacy of second-line regimens for
    BMJ open gastroenterology, 2020, Volume: 7, Issue:1

    Topics: Adult; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Outcome Assessment, Health Care; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Randomized Controlled Trials as Topic; Tetracycline

2020
Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
    Drugs, 2017, Volume: 77, Issue:7

    Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Proton Pump Inhibitors; Quinolones

2017
World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
    Journal of gastroenterology, 2018, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; Clarithromycin; Consensus; Disease Eradication; Drug Resistance, Bacterial; Gastritis; Health Planning Guidelines; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Japan; Metronidazole; National Health Programs; Quinolones; Rifabutin; Stomach Neoplasms

2018
Fourth-generation quinolones in the treatment of
    World journal of gastroenterology, 2018, Aug-07, Volume: 24, Issue:29

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Microbial Sensitivity Tests; Proton Pump Inhibitors; Quinolones; Treatment Outcome

2018
Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.
    Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:1

    Topics: Anti-Bacterial Agents; Comparative Effectiveness Research; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Network Meta-Analysis; Quinolones; Randomized Controlled Trials as Topic; Retreatment

2019
Optimum duration of regimens for Helicobacter pylori eradication.
    The Cochrane database of systematic reviews, 2013, Dec-11, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Quinolones

2013
[Future trends of Helicobacter pylori eradication therapy in Korea].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Mar-25, Volume: 63, Issue:3

    Topics: Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones; Republic of Korea; Treatment Failure

2014
Quinolone-containing therapies in the eradication of Helicobacter pylori.
    BioMed research international, 2014, Volume: 2014

    Topics: Disease Eradication; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones; Tuberculosis

2014
Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
    Journal of gastroenterology and hepatology, 2014, Volume: 29 Suppl 4

    Topics: Alanine; Amoxicillin; Databases, Bibliographic; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Odds Ratio; Proton Pump Inhibitors; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome

2014
[What is new in treating Helicobacter pylori infection?].
    Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Quinolones; Stomach Neoplasms

2015
[Present status and future prospect of 3rd rescue regimen for H. pylori infection].
    Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Quinolones

2009
Guidelines for treatment of Helicobacter pylori in the East and West.
    Expert review of anti-infective therapy, 2011, Volume: 9, Issue:8

    Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Quinolones; Treatment Outcome; Vaccination

2011
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?
    Journal of biochemistry and molecular biology, 2003, Jan-31, Volume: 36, Issue:1

    Topics: Alanine; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cytokines; Disease Models, Animal; Helicobacter Infections; Helicobacter pylori; Humans; Methylnitrosourea; Mice; NF-kappa B; Quinolones; Stomach Neoplasms; Sulfonamides

2003
Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract.
    Alimentary pharmacology & therapeutics, 2003, Volume: 18 Suppl 1

    Topics: Alanine; Anti-Ulcer Agents; Cells, Cultured; Clinical Trials as Topic; Colitis; Gastritis; Helicobacter Infections; Humans; Models, Biological; Quinolones

2003
[Quality of ulcer healing and rebamipide].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11

    Topics: Alanine; Amoxicillin; Animals; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Quinolones; Recurrence; Stomach Ulcer; Wound Healing

2005
[Treatment for Helicobacter pylori: current criteria].
    Recenti progressi in medicina, 2007, Volume: 98, Issue:11

    Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome

2007
Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Alanine; Antioxidants; Apoptosis; DNA Damage; Helicobacter Infections; Helicobacter pylori; Humans; Oxidative Stress; Quinolones; Stomach Neoplasms

1998
[Rebamipide].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2

    Topics: Alanine; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation Mediators; Neutrophil Activation; Oxidative Stress; Peptic Ulcer; Quinolones; Urease

2002
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
    The American journal of gastroenterology, 1990, Volume: 85, Issue:12

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Nitroimidazoles; Quinolones

1990

Trials

25 trial(s) available for carbostyril and Infections, Helicobacter

ArticleYear
Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Metronidazole; Proton Pump Inhibitors; Quinolones; Treatment Outcome

2023
Rebamipide for the Improvement of Gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
    Digestive diseases and sciences, 2022, Volume: 67, Issue:6

    Topics: Alanine; Atrophy; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Pilot Projects; Prospective Studies; Quinolones; Stomach Neoplasms

2022
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
    Terapevticheskii arkhiv, 2018, Aug-27, Volume: 90, Issue:8

    Topics: Adult; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Prospective Studies; Quinolones; Treatment Outcome

2018
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, m
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015, Volume: 18, Issue:3

    Topics: Aged; Alanine; Anti-Bacterial Agents; Clarithromycin; Dissection; Early Detection of Cancer; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinolones; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome

2015
Rebamipide improves chronic inflammation in the lesser curvature of the corpus after Helicobacter pylori eradication: a multicenter study.
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Aged; Aged, 80 and over; Alanine; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Quinolones; Stomach

2015
Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study.
    Clinical drug investigation, 2015, Volume: 35, Issue:10

    Topics: Alanine; CDX2 Transcription Factor; Disease Progression; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Homeodomain Proteins; Humans; Male; Metaplasia; Middle Aged; Peptides; Precancerous Conditions; Quinolones; Stomach Neoplasms; Trefoil Factor-3

2015
Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2009, Volume: 92, Issue:9

    Topics: Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Stomach Ulcer; Treatment Outcome

2009
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
    Digestion, 2011, Volume: 84, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Quinolones; Stomach Ulcer; Treatment Outcome; Wound Healing; Young Adult

2011
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Anti-Ulcer Agents; Breath Tests; False Negative Reactions; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Piperidines; Predictive Value of Tests; Quinolones; Urea

2003
Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Administration, Oral; Adult; Electrocardiography; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Indoles; Placebos; Psychometrics; Quinolones

2003
Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial.
    Alimentary pharmacology & therapeutics, 2003, Volume: 18 Suppl 1

    Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Stomach Ulcer

2003
A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
    Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:1 Pt 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Pilot Projects; Quinolones; Stomach Ulcer; Treatment Outcome

2006
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
    Journal of gastroenterology, 2007, Volume: 42, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Prevalence; Proton Pump Inhibitors; Quinolones; Retrospective Studies; Stomach Ulcer; Treatment Outcome

2007
Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: a randomized sucralfate-controlled multicenter trial in China-STARS study.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:11

    Topics: Adult; Alanine; Anti-Inflammatory Agents; Anti-Ulcer Agents; China; Dinoprostone; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Malondialdehyde; Middle Aged; Quinolones; Sucralfate

2008
An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:11

    Topics: Adult; Alanine; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Endoscopy, Gastrointestinal; Endpoint Determination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Quinolones; Thailand; Young Adult

2008
Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; Chemokines; Cytokines; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Humans; Lansoprazole; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Quinolones

1998
Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Aged; Alanine; Anti-Ulcer Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Recurrence; Stomach Ulcer; Treatment Outcome

1998
Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Adult; Aged; Alanine; Antioxidants; Apoptosis; Catalase; Cytokines; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Glutathione Peroxidase; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Quinolones; Reactive Oxygen Species; Superoxide Dismutase; Treatment Outcome

1998
Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Quinolones; Stomach Ulcer; Treatment Outcome

1998
Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Adult; Aged; Alanine; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Quinolones; Stomach Ulcer; Treatment Outcome

1998
A short-term eradication therapy for Helicobacter pylori acute gastritis.
    Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Quinolones; Stomach; Time Factors

2000
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:10

    Topics: Abdominal Pain; Adult; Alanine; Antacids; Anti-Ulcer Agents; Double-Blind Method; Dyspepsia; Eructation; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; Treatment Outcome

2001
[Effect of antiulcer agents on the urea breath test--Comparison between rebamipide and ecabet sodium].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2002, Volume: 99, Issue:1

    Topics: Abietanes; Alanine; Anti-Ulcer Agents; Breath Tests; Diterpenes; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Predictive Value of Tests; Quinolones; Urea

2002
Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:2

    Topics: Adult; Alanine; Antioxidants; Chemokine CCL5; Cytokines; Drug Therapy, Combination; Duodenal Ulcer; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-1; Interleukin-8; Male; Quinolones; Tumor Necrosis Factor-alpha; Tyrosine

2002
Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:4

    Topics: Alanine; Anti-Ulcer Agents; Drug Administration Schedule; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pepsinogens; Quinolones; Stomach

2002

Other Studies

37 other study(ies) available for carbostyril and Infections, Helicobacter

ArticleYear
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg).
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:10

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Moxifloxacin; Penicillins; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Tetracycline

2022
Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
    Digestive diseases (Basel, Switzerland), 2023, Volume: 41, Issue:3

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Serbia; Tetracycline; Treatment Outcome

2023
Eradicating H. pylori.
    The American journal of gastroenterology, 2019, Volume: 114, Issue:12

    Topics: Adenocarcinoma; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Drug Therapy, Combination; Esophageal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Mortality; Myocardial Infarction; Patient Selection; Practice Guidelines as Topic; Quinolones; Risk; Risk Assessment; Stomach Neoplasms; United States

2019
Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:8

    Topics: Adult; Anti-Bacterial Agents; China; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Quinolones; RNA, Bacterial; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S

2021
[Rebamipide: evidence base for use in gastroenterology].
    Terapevticheskii arkhiv, 2020, Dec-15, Volume: 92, Issue:12

    Topics: Alanine; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones

2020
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Austria; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Genes, Bacterial; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Histocytochemistry; Humans; Male; Middle Aged; Prospective Studies; Quinolones; Real-Time Polymerase Chain Reaction; Young Adult

2018
Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection.
    Helicobacter, 2018, Volume: 23, Issue:2

    Topics: Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones; Treatment Outcome

2018
[The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2018, 04-25, Volume: 71, Issue:4

    Topics: Abietanes; Adult; Aged; Alanine; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Proton Pump Inhibitors; Quinolones; Retrospective Studies; Treatment Outcome

2018
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
    Helicobacter, 2019, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Practice Guidelines as Topic; Quinolones; Young Adult

2019
Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study.
    BMC infectious diseases, 2019, May-21, Volume: 19, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Quinolones; Tanzania; Tertiary Care Centers; Treatment Failure; Young Adult

2019
Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
    Revista espanola de enfermedades digestivas, 2019, Volume: 111, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quinolones; Tetracycline; Young Adult

2019
High secondary resistance to quinolones in German Helicobacter pylori clinical isolates.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Quinolones

2013
An integrated microfluidic system for diagnosis of the resistance of Helicobacter pylori to quinolone-based antibiotics.
    Biosensors & bioelectronics, 2016, Apr-15, Volume: 78

    Topics: Biosensing Techniques; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Microfluidics; Polymorphism, Single Nucleotide; Quinolones

2016
Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
    Biochemical pharmacology, 2016, 08-01, Volume: 113

    Topics: Alanine; Animals; Anticarcinogenic Agents; Antigens, Bacterial; Apoptosis; Bacterial Proteins; beta Catenin; Cell Line, Tumor; Cell Self Renewal; Helicobacter Infections; Helicobacter pylori; Humans; In Situ Nick-End Labeling; Mice, SCID; Quinolones; Signal Transduction; Stomach Neoplasms; Xenograft Model Antitumor Assays

2016
Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: evaluations with endoscopic gastrin test.
    Digestive diseases and sciences, 2009, Volume: 54, Issue:7

    Topics: Adult; Alanine; Anti-Ulcer Agents; Chromatography, Ion Exchange; Endoscopy, Gastrointestinal; Female; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mucins; Quinolones

2009
Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication.
    Digestion, 2009, Volume: 79, Issue:4

    Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Gerbillinae; Hedgehog Proteins; Helicobacter Infections; Helicobacter pylori; Humans; Quinolones

2009
Rebamipide: a gastrointestinal protective drug with pleiotropic activities.
    Expert review of gastroenterology & hepatology, 2010, Volume: 4, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Alanine; Alendronate; Allopurinol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Drug Interactions; Gastritis; Helicobacter Infections; Humans; Male; Mice; Quinolones; Randomized Controlled Trials as Topic; Rats; Stomach Ulcer

2010
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline

2010
In vitro activity of DX-619, a des-F(6)-quinolone, against Helicobacter pylori.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Pyrrolidines; Quinolones; Young Adult

2011
Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan.
    Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:9

    Topics: Adult; Aged; Anti-Bacterial Agents; Asian People; Breath Tests; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Patient Selection; Phenotype; Predictive Value of Tests; Quinolones; Ribotyping; Stomach; Treatment Failure

2011
Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
    Helicobacter, 2012, Volume: 17, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mutation; Naphthyridines; Quinolones; Taiwan

2012
Anti-gastritis and wound healing effects of Momordicae Semen extract and its active component.
    Immunopharmacology and immunotoxicology, 2013, Volume: 35, Issue:1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Calcitonin Gene-Related Peptide; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Male; Mice; Momordica; Plant Extracts; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Somatostatin; Saponins; Seeds; Skin; Wound Healing

2013
Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:7

    Topics: Acetic Acid; Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Cell Division; Epithelium; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Neutrophil Infiltration; Quinolones; Stomach Ulcer; Wound Healing

2002
Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.
    Journal of gastroenterology, 2002, Volume: 37, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Quinolones

2002
Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils.
    Alimentary pharmacology & therapeutics, 2003, Volume: 18 Suppl 1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Chemokines; Cimetidine; Gastrins; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Neutrophils; Peroxidase; Quinolones; Tumor Necrosis Factor-alpha

2003
Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice.
    Alimentary pharmacology & therapeutics, 2003, Volume: 18 Suppl 1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Apoptosis; Blotting, Western; Cytokines; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Immunohistochemistry; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; NF-kappa B; Protein Binding; Proteins; Quinolones; RNA, Messenger

2003
Interaction of leptin with gastric myofibroblast transdifferentiation in Helicobacter pylori-infected Mongolian gerbils: the effect of rebamipide.
    Alimentary pharmacology & therapeutics, 2003, Volume: 18 Suppl 1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Autoradiography; Cell Differentiation; Fibroblasts; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Immunohistochemistry; Leptin; Quinolones

2003
Gastric Helicobacter infection inhibits development of oral tolerance to food antigens in mice.
    Infection and immunity, 2003, Volume: 71, Issue:9

    Topics: Administration, Oral; Alanine; Anaphylaxis; Animals; Antigen Presentation; Antigens; Chickens; Female; Gastritis; Helicobacter Infections; Immune Tolerance; Immunity, Mucosal; Immunoglobulin E; Immunoglobulin G; In Vitro Techniques; Intestines; Mice; Mice, Inbred C3H; Muramidase; Ovalbumin; Quinolones; T-Lymphocytes

2003
[Antibacterial activity of a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11

    Topics: Alkaloids; Animals; Chromatography, Thin Layer; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Chinese Herbal; Evodia; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Plant Extracts; Quinolines; Quinolones

2005
Quinolone resistance in Helicobacter pylori isolates in Germany.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Quinolones

2007
Effect of rebamipide on the colonic barrier in interleukin-10-deficient mice.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Colon; Disease Models, Animal; Female; Flow Cytometry; Helicobacter hepaticus; Helicobacter Infections; Interleukin-10; Intestinal Mucosa; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Quinolones; Specific Pathogen-Free Organisms; T-Lymphocytes

2007
Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients: a study using logistic regression analysis.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2007, Volume: 12, Issue:4

    Topics: Adult; Aged; Alanine; Anti-Ulcer Agents; Bone Diseases; Cyclooxygenase 2 Inhibitors; Diclofenac; Endoscopy; Famotidine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Life Style; Male; Middle Aged; Outpatients; Peptic Ulcer; Prospective Studies; Quinolones; Risk Factors

2007
Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Alanine; Animals; Anti-Ulcer Agents; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Quinolones; Stomach Ulcer

1998
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
    Bioorganic & medicinal chemistry letters, 1998, Aug-18, Volume: 8, Issue:16

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Stability; Fluoroquinolones; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Ofloxacin; Quinolones; Solutions; Structure-Activity Relationship; Ultraviolet Rays

1998
Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis.
    Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:5

    Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Gastric Mucosa; Helicobacter; Helicobacter Infections; Mice; Mice, Inbred C57BL; Permeability; Quinolones

2000
Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:2

    Topics: Alanine; Anti-Ulcer Agents; Blotting, Northern; Blotting, Western; Ceramides; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Mitogen-Activated Protein Kinases; NF-kappa B; Quinolones; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured

2001
Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide.
    Digestive diseases and sciences, 2001, Volume: 46, Issue:7

    Topics: Alanine; Anti-Ulcer Agents; Cell Membrane Permeability; Epithelial Cells; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interferon-gamma; Interleukin-1; Quinolones; Tumor Cells, Cultured

2001